These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22136093)

  • 21. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
    Akhondzadeh S; Fallah J; Mohammadi MR; Imani R; Mohammadi M; Salehi B; Ghanizadeh A; Raznahan M; Mohebbi-Rasa S; Rezazadeh SA; Forghani S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):32-6. PubMed ID: 19772883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.
    McDougle CJ; Scahill L; McCracken JT; Aman MG; Tierney E; Arnold LE; Freeman BJ; Martin A; McGough JJ; Cronin P; Posey DJ; Riddle MA; Ritz L; Swiezy NB; Vitiello B; Volkmar FR; Votolato NA; Walson P
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):201-24. PubMed ID: 10674197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study.
    Lindsay RL; Eugene Arnold L; Aman MG; Vitiello B; Posey DJ; McDougle CJ; Scahill L; Pachler M; McCracken JT; Tierney E; Bozzolo D
    J Intellect Dev Disabil; 2006 Dec; 31(4):204-9. PubMed ID: 17178532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness.
    Malone RP; Maislin G; Choudhury MS; Gifford C; Delaney MA
    J Am Acad Child Adolesc Psychiatry; 2002 Feb; 41(2):140-7. PubMed ID: 11837403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal movements with the addition of clindamycin to risperidone in a girl with autism.
    Malone RP; Harvey JA
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):221-2. PubMed ID: 18439121
    [No Abstract]   [Full Text] [Related]  

  • 26. Risperidone in children with autism and serious behavioral problems.
    Valiquette G
    N Engl J Med; 2002 Dec; 347(23):1890-1; author reply 1890-1. PubMed ID: 12472071
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug therapy in autism.
    Frischauf E
    J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):577. PubMed ID: 9136488
    [No Abstract]   [Full Text] [Related]  

  • 28. The treatment of autistic children with risperidone.
    Dodig-Curković K; Curković M; Radić J; Radić M
    Coll Antropol; 2011 Jan; 35 Suppl 1():297-301. PubMed ID: 21648351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risperidone-Induced Acute Respiratory Distress in an Adolescent with Autism.
    Chen F
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):851-852. PubMed ID: 27220113
    [No Abstract]   [Full Text] [Related]  

  • 32. Risperidone use in the treatment of behavioral symptoms in children with autism.
    West L; Waldrop J
    Pediatr Nurs; 2006; 32(6):545-9. PubMed ID: 17256292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic drugs in children with autism.
    Morgan S; Taylor E
    BMJ; 2007 May; 334(7603):1069-70. PubMed ID: 17525405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olanzapine-induced double incontinence.
    Sagar R; Varghese ST; Balhara YP
    Indian J Med Sci; 2005 Apr; 59(4):163-4. PubMed ID: 15876782
    [No Abstract]   [Full Text] [Related]  

  • 35. Incontinence after piperacetazine treatment.
    Lowenstein H
    Can Psychiatr Assoc J; 1973 Apr; 18(2):173. PubMed ID: 4145184
    [No Abstract]   [Full Text] [Related]  

  • 36. Risperidone: a potential treatment for autism.
    Posey DJ; McDougle CJ
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1212-6. PubMed ID: 12211417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An open trial of risperidone in young autistic children.
    Nicolson R; Awad G; Sloman L
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):372-6. PubMed ID: 9549957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of long-term use of risperidone on body weight of children with an autism spectrum disorder.
    Demb H; Valicenti-McDermott M; Navarro A; Ayoob KT
    J Clin Psychopharmacol; 2011 Oct; 31(5):669-70. PubMed ID: 21881456
    [No Abstract]   [Full Text] [Related]  

  • 39. The autistic-spectrum disorders.
    Rapin I
    N Engl J Med; 2002 Aug; 347(5):302-3. PubMed ID: 12151466
    [No Abstract]   [Full Text] [Related]  

  • 40. Multifocal atrial tachycardia caused by risperidone.
    Oner T; Akdeniz C; Adaletli H
    Int J Cardiol; 2016 Jan; 203():855-7. PubMed ID: 26599751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.